BioRender Icon

Adult female (stage II obesity)

Adult female (stage II obesity) - Editable icon of An adult female with stage II obesity, viewed from the anterior front side in anatomical position
[{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9c3/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9c3/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9c2/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9c2/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9c1/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9c1/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9c0/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9c0/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9bf/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9bf/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9be/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9be/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9bd/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9bd/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9bc/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9bc/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9bb/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9bb/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9ba/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9ba/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9b9/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9b9/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9b8/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9b8/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9b7/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9b7/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9b6/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9b6/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9b5/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9b5/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9b4/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9b4/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9b3/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9b3/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9b2/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9b2/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9b1/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9b1/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9b0/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9b0/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9af/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9af/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9ae/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9ae/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9ad/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9ad/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9ac/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9ac/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9ab/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9ab/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9aa/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9aa/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9a9/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9a9/63bd84ea2fab620022c3c7a6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63bdbec52fab620022c3c9a8/63bd84ea2fab620022c3c7a6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63bdbec52fab620022c3c9a8/63bd84ea2fab620022c3c7a6.png"}]
Use This Icon – Free
No credit card required to sign up.

This icon is fully editable in BioRender

  • Add text, shapes, & other icons
  • Search 50,000+ scientifically accurate icons
  • Recolor and rearrange every icon, line, & label
  • Export or share for any use case
Scientist Avatars

Join 4M+ scientists already making publication-ready figures

Go from icons to finished figure – in minutes

  • Search from 50,000+ scientifically accurate, peer-reviewed icons
  • Customize with labels, shapes, and additional icons – everything is completely editable
  • Export or share your figures with collaborators

Not quite the right icon? Discover more.

Search 50,000+ icons across 30+ life-science fields.

search icon
arrow-right
Keywords
female obesity,obese female,obese woman,stage II obesity,stage 2 obesity,stage II,fat female,fat woman,overweight female,overweight woman,adult female,human body woman,person,body,people,figure,girl,face,eyes open,hair,overweight,body mass index,high BMI,BMI,fat,obesity,obese,chubby,large size,fatness,II,insulin,diabetes,hypertension,anterior,front,anatomical position,female obesity,obese female,obese woman,stage II obesity,stage 2 obesity
View More

Try a synonym, or sign up to request an icon from the app.

Image types

Adult female (stage II obesity) icon JPEG

Adult female (stage II obesity) icon PNG

Adult female (stage II obesity) icon SVG

Adult female (stage II obesity) icon GIF

Biorender Icon FAQs

How are scientists using the Adult female (stage II obesity) icon in their work?

BioRender users often use the Adult female (stage II obesity) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Human Anatomy.

Can I use this icon in a BioRender figure or scientific illustration?

Yes, the Adult female (stage II obesity) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Adult female (stage II obesity) icon customizable in BioRender?

Most icons in BioRender, including the Adult female (stage II obesity) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Adult female (stage II obesity) icon for publication or presentations?

Yes, figures containing the Adult female (stage II obesity) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Adult female (stage II obesity) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Adult female (stage II obesity) icon — especially those focused on Human Anatomy. You can search BioRender’s template library or add this icon manually to any canvas.

What is BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Adult female (stage II obesity) icon along with our library of more than 30,000 life science icons.

Looking for science content?

Browse 50K+ icons and templates that are peer-reviewed, easy to use, and free.

Find yours now
x icon